The sections below work through those three questions in the order a clinician tends to think about them, starting with the size of the rise and ending with the follow up tests that usually sort a mild elevation from one that needs a closer look.
ALT, or alanine aminotransferase, is an enzyme concentrated inside liver cells, and the blood test measures how much of it has leaked out into circulation. Liver cells hold far more of it than blood does, so when those cells are stressed, inflamed or injured, the level climbs. That makes it a sensitive signal of liver cell membrane stress rather than a measure of how well the liver is doing its work. It is reported in units per litre (U/L) and usually appears on a liver panel next to AST, ALP, GGT, bilirubin and albumin. The companion biomarker page covers the test itself, the ranges and what a single value can and cannot show. This guide picks up at the point where a number starts to prompt follow up.
There is no single number that flips a result from fine to concerning, because the size of the rise, the pattern around it and its persistence all change the answer. Still, the starting point is always the range printed on your own report.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| ALT, adult men | 7 to 56 U/L | 10 to 25 U/L |
| ALT, adult women | 7 to 33 U/L | 8 to 19 U/L |
| ALT, general adult | 7 to 56 U/L | 10 to 25 U/L |
Values are in U/L (units per litre). These are typical lab reference ranges, and they vary by lab, age and sex, so compare your result against the range on your own report. The optimal ranges shown are FitScript's optimization targets, not diagnostic cut offs, and a value sitting outside them is not a diagnosis of anything.
Reviews of abnormal liver enzymes commonly sort elevations into bands, borderline, mild, moderate and marked, because the band sets the pace of the work up 1. In broad terms, a value a little over the top of the range in someone who feels well usually prompts a repeat test plus a review of medications, alcohol and recent exercise. A value several times the upper limit prompts a wider work up sooner. A markedly raised value, often described in clinical reviews as more than ten times the upper limit, points toward acute liver cell injury such as a drug reaction, acute viral hepatitis or a temporary loss of blood flow to the liver, and is worth discussing with a clinician promptly 2.
Context moves the threshold. A reading of 60 U/L two days after a first long run reads differently from the same 60 U/L in someone with rising waist circumference, high triglycerides and a creeping A1c. Same number, different conversation.
Usually not on its own, which is why the standard next step after a mild unexplained elevation is a repeat test rather than a specialist referral. ALT fluctuates. A heavy training week, a new over the counter medicine, a stomach bug, a weekend of drinking or a recent illness can all nudge it up, and the number often drifts back without anything being done.
What changes the picture is persistence. An elevation that is still there on a repeat sample weeks later, in someone who has paused the obvious culprits, is a different signal from a one off blip. Clinical commentary makes the point bluntly, that asymptomatic enzyme elevations are not trivial and deserve a structured explanation rather than a shrug 3. Feeling fine does not mean the liver is fine, because early liver injury is usually silent.
A few practical points make a repeat test more informative. Avoid hard or unfamiliar exercise in the days before the draw, since muscle work can lift transaminases. Avoid alcohol in that window. Use the same lab where possible, because reference ranges and assay methods differ between labs and a change in method can look like a change in you. Bring a full list of prescription medicines, over the counter painkillers, herbal products and training supplements, since several of those belong on the differential. And never leave an abnormal result unexamined on the assumption that it will sort itself out.
Yellowing of the skin or eyes, dark urine, pale stools, severe or persistent pain in the upper right abdomen, vomiting that will not settle, confusion or unusual drowsiness, and easy bruising or bleeding are the features that call for urgent medical care rather than a scheduled appointment. Those symptoms reflect function rather than leakage.
The distinction matters. ALT tells you that liver cells are leaking enzyme. Jaundice tells you bilirubin is not being cleared. Confusion can reflect the liver failing to clear nitrogen waste. Bruising and bleeding can reflect reduced production of clotting factors. Those are signals about the liver's working capacity, and they sit on a different urgency tier from a number on a panel.
Two more situations deserve a same day call. The first is a fever, rash or marked fatigue starting within weeks of a new medicine, which can suggest a drug related reaction. The second is new upper abdominal pain, headache, visual changes or swelling in pregnancy, which needs assessment the same day 4.
They tell you which compartment of the liver is under strain, which is often more informative than the ALT number by itself. Clinicians read liver panels as patterns, not as isolated values.
A hepatocellular pattern means ALT and AST are raised out of proportion to ALP, and points toward injury to liver cells themselves. A cholestatic pattern means ALP and GGT dominate, and points toward bile flow being obstructed or impaired, from gallstones to drug effects. A mixed pattern sits between the two. GGT is useful as a tie breaker, because a raised ALP with a normal GGT often points to bone rather than liver.
The AST to ALT ratio, known as the De Ritis ratio, is another pattern clue. A ratio above two with modest absolute values is a classic alcohol related signature, while most other liver cell injury keeps ALT above AST.
Bilirubin, albumin, INR and platelet count round out the picture. Those four speak to function and to scarring rather than to leakage, and a change in them alongside a raised ALT raises the priority of the visit considerably 1.
Yes, and it is one of the most common harmless reasons a healthy person sees a mildly raised ALT. Skeletal muscle contains both AST and ALT, and strenuous or unfamiliar effort, particularly eccentric loading such as downhill running or a heavy new lifting session, releases enzyme from muscle into blood. Transaminases are not liver exclusive proteins.
The way to separate muscle from liver is to look at the markers that muscle dominates. Creatine kinase rises sharply with muscle damage and barely moves with most liver conditions. LDH often follows muscle too. If CK is high, AST is high and ALT is only modestly up, muscle is a plausible explanation, especially when it follows a known hard session. If GGT and bilirubin are also raised, muscle is a weaker explanation.
The practical move is simple. Repeat the test after a period of light activity, with no heavy or novel training in the days before the draw, and see whether the number falls. A value that normalises after a training taper has explained itself. A value that stays up despite the taper has not, and deserves a clinician's review.
More than most people expect, which is why a full medication and supplement list is part of every sensible work up. Research suggests that statin therapy is associated with mild transaminase elevations that are frequently asymptomatic, and the decision about whether any change is needed belongs to the prescribing clinician 5. Even medicines not usually associated with the liver can be implicated. A published case report describes transaminase elevation during teriparatide therapy, which shows why the timing of a new medicine relative to a new lab result is always worth mapping 6.
Other categories that regularly appear on the differential include some prescription and over-the-counter medicines taken regularly, and anabolic steroids or other compounds bought outside a pharmacy. Herbal and performance supplements belong on the same list, with concentrated green tea extract, kava and various multi ingredient fat burner blends among the better documented offenders.
Two rules keep this safe. Never stop or change a prescribed medicine on the strength of a lab number, because stopping the wrong thing carries its own risk. And for any prescription therapy, a licensed provider evaluates whether it remains appropriate and whether the enzyme pattern warrants a change. Non prescription supplements are a different matter, and a clinician will often ask you to pause them while the picture is clarified.
In adults with a persistent mild elevation and no other obvious cause, metabolic fatty liver is the most common explanation clinicians consider first. Fat accumulating inside liver cells is associated with low grade inflammation and a steady, modest enzyme leak, usually in the range that sits above the optimal window but well inside a band most people would call unremarkable.
Research suggests that alanine aminotransferase is associated with non alcoholic fatty liver disease and tracks with type 2 diabetes and cardiovascular risk, which is why a mildly raised value is read as a metabolic flag rather than a purely hepatic one 7. The markers that give the elevation meaning are therefore metabolic. Fasting insulin, HbA1c, triglycerides, HDL, the triglyceride to HDL ratio, waist circumference and blood pressure usually tell you more about a mildly raised value than another liver enzyme would.
The encouraging part is that this is the most modifiable version of the story. ALT often moves with body composition, visceral fat, sleep, alcohol intake and glycaemic control, so a value that drifted up over years can drift back down as those inputs change. That is a pattern commonly seen in practice rather than a promise about any individual, and the pace and extent vary from person to person. A clinician can tell you whether imaging or a fibrosis assessment is worth adding before you assume the explanation is simply metabolic.
It changes both the likely cause and the pattern, so an honest alcohol history is one of the highest yield parts of the assessment. Alcohol related liver injury classically produces an AST that exceeds ALT, often by a ratio above two, with both values frequently only modestly raised, alongside a raised GGT and sometimes a raised MCV on the blood count 1.
That pattern matters because the absolute numbers can understate the degree of underlying change. A person with significant alcohol related liver injury may have enzyme values a clinician would call mildly suboptimal, while someone with acute viral hepatitis and a far better outlook may have values many times higher. Size alone is a poor proxy for seriousness.
Short term drinking also produces short term changes. A heavy weekend before a blood draw can lift enzymes without implying established disease. Because of that, clinicians often ask for a defined alcohol free period before a repeat test, so the retest reflects a baseline rather than a recent episode. Under reporting intake is the one thing that reliably derails the process, since it pushes the work up toward expensive tests looking for an explanation that is already known.
Yes, and this is the single most misunderstood point about ALT. The test measures enzyme leaking from injured cells, so in advanced scarring, where fewer functioning liver cells remain, the value can fall back into range or even sit low while the liver is doing poorly. A normal result rules out nothing on its own 3.
This is why clinicians do not stop at transaminases when the history suggests risk. A falling platelet count, a low albumin, a rising INR, a raised bilirubin, or an enlarged spleen on imaging can all indicate established liver change in the presence of entirely ordinary looking enzymes. Non invasive fibrosis scores, which combine routine labs such as platelets, AST, ALT and age, and elastography, which estimates liver stiffness, are the usual tools for assessing scarring when the enzymes are not telling the whole story 1.
The practical takeaway is that a normal ALT is reassuring in a person with no risk factors and no symptoms, and much less reassuring in someone with longstanding metabolic risk, significant alcohol intake, a family history of liver disease, or known viral hepatitis. In those situations, the right question for a clinician is not whether the enzyme is normal but whether the liver has been assessed properly.
A mild elevation that persists is best read as a long term risk signal rather than an acute problem. Studies indicate that, in older individuals, elevated liver enzymes are associated with higher mortality over follow up, which is part of why clinicians dislike leaving an unexplained elevation undocumented 8. The association does not mean the enzyme itself causes harm. It means the enzyme is often reporting on something underneath it, usually metabolic, that does.
That framing fits with the fatty liver literature, where ALT is associated with the same cluster of problems that drives cardiometabolic risk more broadly 7. So a value that has sat above the range for a couple of years in an otherwise well adult is worth explaining, not because today is urgent, but because the explanation usually points at something that responds to attention over the next few years.
The reverse is also worth saying plainly. A persistently raised value is not a verdict. Many people find the cause is a medication, a supplement, an untreated metabolic pattern or a lifestyle factor that can be addressed, and the number responds. The failure mode to avoid is the one where nobody looks, the result is repeated annually, and a modifiable cause goes unexamined for a decade.
A low ALT is rarely flagged by labs and is almost never urgent, but it is not meaningless. The enzyme requires pyridoxal 5 phosphate, the active form of vitamin B6, to function, so low B6 status can reduce measured activity. Low ALT is also seen alongside reduced muscle mass, low protein intake and frailty, since the enzyme is present in muscle tissue as well as liver.
In an optimization context, a value sitting well below the optimal window is usually read as a prompt to look at protein intake, B6 status, training load and overall muscle mass, rather than as a liver finding at all. It becomes more interesting when it sits alongside other low markers such as a low albumin, a low total protein or a low creatinine, which together can suggest reduced lean mass or poor nutritional status.
There is also the scenario mentioned earlier, where a very low or deceptively normal enzyme accompanies advanced liver scarring. That is uncommon, and it almost always comes with other clues in the panel or the history. A single low value in a well nourished, physically active adult with normal albumin and platelets is not a cause for concern, and is worth mentioning at your next appointment rather than chasing.
The standard sequence starts with repeating the liver panel and widening it, then working through the causes that are common, treatable or important not to miss. A structured approach to abnormal liver enzymes usually includes a repeat panel with GGT, fractionated bilirubin, albumin and INR, a full blood count for platelets, hepatitis B and C serology, iron studies including ferritin and transferrin saturation, and an abdominal ultrasound 2.
Depending on age, history and the pattern, a clinician may add autoimmune markers such as ANA and anti smooth muscle antibody with immunoglobulins, coeliac serology, thyroid function, alpha 1 antitrypsin, and creatine kinase when a muscle source is plausible. Fibrosis scoring and elastography are used when scarring is a realistic concern.
Tracking matters as much as the one off panel. Because ALT moves with training, alcohol, medication changes and metabolic shifts, a series of values across a year tells a far clearer story than a single annual snapshot. FitScript's membership covers 150+ biomarkers tested per year, with Atlas, FitScript's AI health advisor, interpreting results in the context of the markers around them and a licensed provider making any clinical decisions.
This article is educational and is not medical advice.
Some contexts compress the timeline, turning a result that would otherwise be repeated in a few weeks into one worth discussing with a clinician promptly. Pregnancy is the clearest example. Raised liver enzymes with low platelets and evidence of red cell breakdown describe HELLP syndrome, a serious pregnancy complication whose recognition and management are time critical, so any abnormal liver enzyme in pregnancy warrants same day obstetric assessment 4.
In people with HIV, transaminase elevation carries a broader differential, including co infection with hepatitis B or C, medication effects and opportunistic processes, and clinical commentary stresses that the significance of a raised value depends heavily on that wider context 9.
Other accelerators include a new medicine started in the previous weeks, immune suppression, recent travel or known exposure to hepatitis A, rapid unintentional weight loss, a known liver condition under monitoring, and any elevation in a child or adolescent, where inherited and metabolic causes feature more prominently and specialist input comes earlier.
Book urgently for jaundice, dark urine, severe abdominal pain, confusion, persistent vomiting or unusual bruising. Book promptly, within days rather than months, for a markedly raised value, for any elevation in pregnancy, for an elevation alongside a rising bilirubin, a falling platelet count, a low albumin or a prolonged INR, for an elevation that began soon after a new medicine, and for an elevation in a child.
Book a routine appointment for a mild elevation that is still present on a repeat test, for any elevation in someone with metabolic risk factors, significant alcohol intake, a family history of liver disease or known viral hepatitis, and for a value that has been slowly climbing across several years even if each individual result looked acceptable 3.
And simply note, without alarm, a single mild elevation in a well person that followed hard training, an illness or a short course of a medicine, then retest under cleaner conditions. That is the group where the number most often returns to baseline on its own. Whatever band your result falls into, discuss it and any treatment decisions with a clinician or licensed provider who can see your full history, your medication list and the rest of your panel.
A value in that vicinity usually sits just above a typical lab reference range and is considered a mild elevation rather than an emergency. In a person who feels well, the standard next step is a repeat test after avoiding hard training and alcohol, along with a review of medications and supplements. It becomes more interesting if it persists, if AST, bilirubin, GGT or platelets are also abnormal, or if metabolic risk factors are present. Discuss the result with a clinician who can see your full panel.
It depends entirely on the cause, so there is no reliable calendar estimate. An elevation driven by a hard training block or a short illness often settles once the trigger is removed, while one driven by metabolic fatty liver tends to move over months as the underlying picture changes. Rather than planning around a timeframe, follow the retest interval your clinician sets and compare values from the same lab.
It can nudge them up, particularly GGT and AST, which is why clinicians often ask for an alcohol free period before a repeat test. Alcohol related liver injury classically shows AST exceeding ALT, often with a raised GGT, and the absolute numbers can stay modest even when underlying change is significant. Being accurate about intake is the fastest way to get the right interpretation.
Yes. Skeletal muscle contains both AST and ALT, and strenuous or unfamiliar effort, especially heavy lifting or downhill running, can release enzyme into the blood. A high creatine kinase alongside the transaminases points toward a muscle source. The simplest check is to repeat the test after several days of light activity and see whether the value falls.
ALT itself does not require fasting, but it is usually drawn as part of a panel that includes glucose, insulin or a lipid profile, and those markers often do. Follow the instructions your lab or clinician gives for the full panel. More useful than fasting status is avoiding heavy or novel exercise and alcohol in the days before the draw, and using the same lab each time so results are comparable.
No single number indicates liver damage on its own, and ALT is a signal of liver cell stress rather than a diagnosis. Clinicians weigh how far above the range the value sits, whether it persists on a repeat test, how it relates to AST, ALP, GGT and bilirubin, and whether function markers such as albumin, INR and platelets have shifted. A markedly raised value is worth discussing with a clinician promptly, and only a clinician can determine the cause.
Some can. Concentrated green tea extract, kava, multi ingredient fat burners, and anabolic androgenic compounds or unregulated chemicals bought outside a pharmacy are among those that can. Bring a full list of everything you take to your appointment, including items you would not describe as medication. A clinician will often ask you to pause non prescription supplements while the picture is clarified. Never stop a prescribed medicine on the strength of a lab number, since a licensed provider evaluates whether it remains appropriate.
Often it can, particularly when the driver is a supplement, alcohol intake, recent training or a metabolic pattern that responds to change in body composition, sleep and glycaemic control. ALT is one of the more responsive markers on a panel. The extent and pace vary from person to person, and the first task is still to identify the cause with a clinician rather than to assume one.
Not necessarily. Because the test measures enzyme leaking from injured cells, advanced scarring with fewer functioning liver cells can show a normal or even low value. In people with longstanding metabolic risk, significant alcohol intake, known viral hepatitis or a family history of liver disease, a clinician may look at platelets, albumin, INR, fibrosis scores and imaging rather than relying on enzymes alone.